Invesco Ltd. - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 86 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$15,712
-7.8%
17,518
+21.2%
0.00%
Q4 2022$17,049
-85.9%
14,448
-10.1%
0.00%
Q3 2022$121,000
+36.0%
16,069
+14.3%
0.00%
Q2 2022$89,000
+17.1%
14,061
+22.7%
0.00%
Q3 2021$76,000
-11.6%
11,461
+13.4%
0.00%
Q2 2021$86,00010,1040.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Simplify Asset Management Inc. 2,700,000$823,5000.09%
683 Capital Management, LLC 2,650,000$808,2500.06%
GSA CAPITAL PARTNERS LLP 355,867$1090.01%
RBF Capital, LLC 391,265$119,3360.01%
UBS OCONNOR LLC 393,975$120,1620.00%
XTX Topco Ltd 15,597$4,7570.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 106,700$32,5440.00%
AMERIPRISE FINANCIAL INC 8,592,471$2,620,7040.00%
DRW Securities, LLC 120,365$370.00%
DFPG INVESTMENTS, LLC 32,430$10,8960.00%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders